info@marketresearchfuture.com   ๐Ÿ“ž  +1 (855) 661-4441(US)   ๐Ÿ“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersรขโ‚ฌโ„ข financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Ascites Market Trends

ID: MRFR//1377-CR | 130 Pages | Author: Rahul Gotadki| August 2019

Global Ascites Market Overview


The Ascites Market Size was valued at USD 1.29 Billion in 2023. The global ascites industry is projected to grow from USD 1.36 Billion in 2024 to USD 2.41 Billion by 2032, exhibiting a CAGR of 3.89% during the forecast period (2024 - 2032).


Ascites Market


Ascites are abnormal fluid that is gathered in the intestinal chamber. Ascites most generally make the occurrence of liver cirrhosis. Its presence is a gateway to high blood pressure. However, some minorly found factors of ascites are heart failure, kidney failure, cancers, and pancreas infection.


Further, when the ascites become malignant, they become the principal cause of ovarian cancer. Moreover, Malignancy connected to ascites can also notice in tumours of the breast, lung, pancreas, gastric, and liver. The physical examination can track ascites when the volume is higher than 1.5 l. However, ultrasound and CT scans are recommended when the fluid gathering is smaller.


Sequana Medical announced in January 2024 the substantive review of alfa pump’s Premarket Approval (PMA) application by the United States Food and Drug Administration (US FDA). The company projects an FDA approval in H2 2024.


OCE-205 was granted Orphan Drug Designation (ODD) by the US FDA for ascites treatment not involving cancer except for etiologies in December 2023.


In 2023, Astellas Pharma revealed that it had executed a licensing deal with Mirati Therapeutics on the development and commercialisation of a drug candidate indicated for ascites. This collaboration is expected to leverage both companies’ capabilities and take the field ahead significantly.


In 2022, Gilead Sciences declared that they had completed the acquisition of Principia Biopharma, a company which is developing new ascites treatment. Gilead Science’s resources and expertise are expected to accelerate the market introduction of this treatment, giving hope to patients with this difficult condition.


Johnson & Johnson entered into a partnership with Arbutus Biopharma in order to develop and commercialize an ascites drug candidate, according to an announcement made on their website in June 2021. Both companies have combined their assets under this agreement, which should result in significant market advancements due to joint efforts.


Novartis submitted its New Drug Application (NDA) for its ascites drug candidate to FDA in March 2020. This marks a major progression towards the development of a therapy against this malady.


COVID-19 Analysis


The scattering cases of the coronavirus pandemic have a great jolt on life around the world. The most affected by COVID-19 are the two departments, i.e., health and economy. Therefore, they have experienced a period of decreased economic activity and depression. The only solution to this crooked situation is to make a blueprint amid this epidemic. According to the report, companies shall aid in the future Ascites market.


Ascites Market Trends


Market Drivers


In fact, the increasing ubiquity of Cirrhosis, modifications in recompense policies, and amplifying fluke of cancer are the major drivers thrusting the Ascites Market growth. For example, a study shown in the Canadian Journal of Gastroenterology and Hepatology in 2016 describes that almost 75% of Cirrhosis ascites patients are brought to hospitals. Furthermore, in the European Region, Cirrhosis for ascites is found rigorously.


Restrain


However, the rigid ground rules and problems connected with Ascites treatment, such as interior bleeding after paracentesis treatment and vulnerability to radiation in chemotherapy, may constrain the outgrowth of the Market till the forecast period. For example, research in Experimental and Molecular Medicine in 2017 discussed that the non-malignant liver tissues could also catalyze envenomed due to high radiation. Thus, it will take less the course of therapy, and most importantly, it can create chronic ramifications such as late fibrosis.


Opportunities


There are many opportunities expected in Market during the forecast period. The main emphasis will be given to the improvement of the capacity to persuade the tests are delivering a greater impact on the opportunities for the market.


Challenges


Challenges are there in lowering the radiations created by chemotherapy. Also, the complications accompanied by ascites treatment can restrain the market's growth.


Cumulative Analysis


The key driver, the rising cases of Cirrhosis for ascites, will propel the market's growth as suggested in the Ascites Market forecast. For example, in the American Cancer Society Report in 2018, it is reported that due to cancer, 609,640 deaths happened. In 2016 Nano Antibiotics got LAT pharma LLC. Moreover, it is a popular biotechnology company that makes new medications to battle against the overpowering problem of Cirrhosis.


Value Chain Analysis


The increasing Ascites Market because of the rising cases of malignant due to ascites and the introduction of new medicines in biotechnology are some assertive prospects. Basically, the demand for medicines and Diagnoses will increase more in the future and can mutinously improve the market's value chain.


Ascites Market Segment Insights


The Ascites Market splintered into types of Diagnosis, Treatment and clients. Moreover, the development among these segments will help you anatomize recess resources of excrescency. So, you can make your game plans to approach the Ascites Market trend and rule on your quick act or practice of employing your strategies on the areas you can distinct target market.


Ascites Types Insights


According to types, the market is divided into transudative ascites and exudates ascites.

Ascites Diagnosis Insights


However, depending on the diagnosis, the Ascites Market size is divided into ultrasound, CT scan, MRI, blood test, laparoscopy, angiography, etc.


Ascites Treatment Insights


Besides, depending on treatment, it is portioned into medication, paracentesis, surgery, etc. Again, medication has various segments: diuretics, special nutrition, and others.


Ascites Route of Administration Insights


Oral, parental and others are the route of administration segment of Ascites Market. Based on clients, the market splintered into hospitals, specialty clinics, home care, and more. However, the hospital and clinic segment rationalized for Ascites Market revenue of USD 838.4 million.

Ascites Allotment Channel Insights


Moreover, depending on the allotment channel, there are hospital pharmacies, retail pharmacies, online pharmacies and more in the market.


Ascites Regional Insights


So, the regional analysis of the Ascites Market is mainly based on the market size information known from the country.
Consequently, according to Ascites Market Research, America, Europe, Asia Pacific, the Middle East, and Africa are the countries covering this market.


To illustrate, North America holds the largest Ascites Market share because all the main product manufacturers are from here. Furthermore, they have high research and development skills and aced professionals and health care lay.
Besides, Europe holds the second largest market because of their increasing liver damage and cancer cases.
However, according to the Ascites Market forecast, Asia Pacific will hold the largest market in the future years. It will happen because the Asia Pacific has leviathan development opportunities of Market.


Moreover, because of being a county full of poverty and fewer development opportunities, the Middle East and Africa hold the least market of Ascites.


Competitive Landscape


The competitive landscape of Market provides details about a competitor. Additionally, some of the game plans followed by the key players are creativity, output evolution, obtainment and progress.


Some substantive key players in Ascites Market are:




  • Square Medical NV of Switzerland

  • BioVie Inc. of the US

  • PharmaCyte of US

  • Fresenius SE & Co. KGaA of Germany

  • BD of US

  • GI Supply of US

  • Medtronic of Ireland



Recent developments



  • BIV201 BioVie Inc. got FDA fast-track denotation in December 2017.

  • In addition, Fresenius & Co and KGaA far-flung their branches in Mihla, Germany, and for this, they shell out USD 11.78 million. It happened in December 2017.

  • Moreover, in April 2017, BD cultivated CD Bard Inc. for the expansion of its branches of the oncology and surgery segment. They outlaid almost USD 24 billion for this venture.



Report Overview

The report overview of Ascites Market consists:



  • Market Overview

  • COVID-19 Analysis

  • Various Market Dynamics

  • Value Chain Analysis

  • Market Segmentation

  • Regional Segmentation

  • Competitive Landscape analysis

  • Recent Development



Ascites Market Segmentation


Ascites Types Outlook




  • Transudative Ascites

  • Exudate Ascites



Ascites Diagnosis Outlook





Ascites Treatment Outlook




  • Surgeries



Ascites End-users Outlook




  • Preface

  • Hospitals and health clinics

  • Nomadic surgical centre

  • Diagnosis centre



Ascites Regional Outlook


America



  • North America

  • South America



Europe



  • Western Europe

  • Eastern Europe



Asia Pacific



  • China

  • Japan

  • India

  • Australia



The Middle East and Africa



  • Middle East



  • UAE



  • Oman



  • Rest of the Middle East



  • Africa


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.